Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

NASCAR Crew Chief Reveals Cancer Diagnosis, GoFundMe Is Made for James Casey and More

August 25th 2023, 3:00pm

Article

From a former patient with cancer lives her dream of working alongside her doctor, to NASCAR crew chief Tommy Baldwin Jr. announcing his cancer diagnosis, this is what’s going on in the oncology space this week.

Celebrating Survival with a Meager Budget

August 5th 2023, 5:00pm

Article

Enjoying things right in front of me.

Nexavar Maintenance Improves Survival for Patients with AML Subset

July 23rd 2023, 5:00pm

Article

Patients with a subset of acute myeloid leukemia may have improved survival rates and lower risk of relapse with Nexavar maintenance.

FDA Approves Vanflyta Regimen for AML Subset

July 21st 2023, 1:18pm

Article

The Food and Drug Administration approved a Vanflyta regimen for patients with FLT-ITD—positive acute myeloid leukemia.

Balancing Volunteerism and Self-Care During Cancer Survivorship

July 20th 2023, 5:00pm

Article

After recovering from a bone marrow transplant to tackle a recurrence of acute myeloid leukemia, I started to volunteer.

A Few Lasting Side Effects That Aren't So Bad

July 15th 2023, 5:00pm

Article

I couldn't believe that I would benefit from some of the side effects of my cancer treatment.

My Psychological Response to a Cancer Diagnosis

June 27th 2023, 5:00pm

Article

I have a confession: I daydreamed of a “last hurrah” should my cancer treatment not work.

Tips I Learned During Inpatient Chemo and Bone Marrow Transplant

June 22nd 2023, 5:00pm

Article

After two diagnoses of acute myeloid leukemia, intense chemo and a bone marrow transplant, I’ve learned some things that helped me along the way.

Pre- or Post-Transplant Xospata Shows Relapse-Free Survival Benefit in AML Group

June 15th 2023, 3:00pm

Article

Findings from a phase 3 trial demonstrated that half of patients with FLT3-ITD-mutant acute myeloid leukemia and detectable minimal residual risk derived a relapse-free survival benefit with Xospata.

Iclusig With Chemo ‘Should Be Standard of Care’ for ALL Subset

June 10th 2023, 3:00pm

Article

Iclusig plus reduced-intensity chemotherapy led to improved outcomes for patients with Philadelphia chromosome (Ph)–positive acute lymphoblastic leukemia, and should be the new standard of care, one expert said.